SIA OpenIR  > 机器人学研究室
Nanoscale quantifying the effects of targeted drug on chemotherapy in lymphoma treatment using atomic force microscopy
Li M(李密); Xiao XB(肖秀斌); Liu LQ(刘连庆); Xi N(席宁); Wang YC(王越超)
作者部门机器人学研究室
关键词Atomic Force Microscopy (Afm) Mechanical Properties Cancer Surface Roughness Drug
发表期刊IEEE Transactions on Biomedical Engineering
ISSN0018-9294
2016
卷号63期号:10页码:2187-2199
收录类别SCI ; EI
EI收录号20164202905112
WOS记录号WOS:000384570200022
产权排序1
资助机构National Natural Science Foundation of China (61503372, 61522312, 61175103, 61375107, 61327014, and 61433017), the Research Fund of the State Key Laboratory of Robotics (No. 2014-Z07), and the CAS FEA International Partnership Program for Creative Research Teams.
摘要The applications of targeted drugs in treating cancers have significantly improved the survival rates of patients. However, in the clinical practice, targeted drugs are commonly combined with chemotherapy drugs, causing that the exact contribution of targeted drugs to the clinical outcome is difficult to evaluate. Quantitatively investigating the effects of targeted drugs on chemotherapy drugs on cancer cells is useful for us to understand drug actions and design better drugs. The advent of atomic force microscopy (AFM) provides a powerful tool for probing the nanoscale physiological activities of single live cells. In this paper, the detailed changes in cell morphology and mechanical properties were quantified on single lymphoma cells during the actions of rituximab (a monoclonal antibody targeted drug) and two chemotherapy drugs (cisplatin and cytarabine) by AFM. AFM imaging revealed the distinct changes of cellular ultramicro structures induced by the drugs. The changes of cellular mechanical properties after the drug stimulations were measured by AFM indenting. The statistical histograms of cellular surface roughness and mechanical properties quantitatively showed that rituximab could remarkably strengthen the killing effects of chemotherapy drugs. The study offers a new way to quantify the synergistic interactions between targeted drugs and chemotherapy drugs at the nanoscale, which will have potential impacts on predicting the efficacies of drug combinations before clinical treatments.
语种英语
WOS标题词Science & Technology ; Technology
WOS类目Engineering, Biomedical
关键词[WOS]ACUTE MYELOID-LEUKEMIA ; NON-HODGKINS-LYMPHOMA ; CANCER-CELLS ; LIVING CELLS ; MONOCLONAL-ANTIBODIES ; CISPLATIN RESISTANCE ; BREAST-CANCER ; MYOSIN-II ; RITUXIMAB ; AFM
WOS研究方向Engineering
引用统计
被引频次:7[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.sia.cn/handle/173321/19269
专题机器人学研究室
通讯作者Liu LQ(刘连庆)
作者单位1.State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang 110016, China
2.Department of Lymphoma, Affiliated Hospital of Military Medical Academy of Sciences, China
3.Department of Electrical and Computer Engineering, Michigan State University, United States
推荐引用方式
GB/T 7714
Li M,Xiao XB,Liu LQ,et al. Nanoscale quantifying the effects of targeted drug on chemotherapy in lymphoma treatment using atomic force microscopy[J]. IEEE Transactions on Biomedical Engineering,2016,63(10):2187-2199.
APA Li M,Xiao XB,Liu LQ,Xi N,&Wang YC.(2016).Nanoscale quantifying the effects of targeted drug on chemotherapy in lymphoma treatment using atomic force microscopy.IEEE Transactions on Biomedical Engineering,63(10),2187-2199.
MLA Li M,et al."Nanoscale quantifying the effects of targeted drug on chemotherapy in lymphoma treatment using atomic force microscopy".IEEE Transactions on Biomedical Engineering 63.10(2016):2187-2199.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Nanoscale quantifyin(1348KB)期刊论文作者接受稿开放获取ODC PDDL浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li M(李密)]的文章
[Xiao XB(肖秀斌)]的文章
[Liu LQ(刘连庆)]的文章
百度学术
百度学术中相似的文章
[Li M(李密)]的文章
[Xiao XB(肖秀斌)]的文章
[Liu LQ(刘连庆)]的文章
必应学术
必应学术中相似的文章
[Li M(李密)]的文章
[Xiao XB(肖秀斌)]的文章
[Liu LQ(刘连庆)]的文章
相关权益政策
暂无数据
收藏/分享
文件名: Nanoscale quantifying the effects of targeted drug on chemotherapy in lymphoma treatment using atomic force microscopy.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。